That’s what this drug company is trying to do. It probably would be better to spend their resources trying to find something new, rather than repackaging old drugs (case in point: BiDil).
Related Stories
More in Uncategorized
Comments
Previous post: Diabetic man mistaken for drunkenness
Next post: The Google Health Advisory Council: Outrage




